2023-08-07 | Mechanism of action of statins | 0:54 | 0 | |
|
2023-08-07 | Mechanism of action of statins | 0:56 | 2 | |
|
2023-08-07 | Drugs causing QT prolongation and torsades de pointes | 2:42 | 31 | |
|
2023-08-07 | Drugs causing QT prolongation and torsades de pointes | 0:56 | 2 | |
|
2023-08-07 | Amiodarone side effects | 1:00 | 25 | |
|
2023-08-07 | Amiodarone side effects | 0:56 | 32 | |
|
2023-08-07 | Drugs used in supraventricular and ventricular arrhythmias | 0:56 | 24 | |
|
2023-08-07 | Drugs used in supraventricular and ventricular arrhythmias | 1:19 | 15 | |
|
2023-08-07 | Antiarrhythmic drugs | 1:51 | 56 | |
|
2023-08-07 | Antiarrhythmic drugs | 0:56 | 10 | |
|
2023-08-03 | Going live | 0:00 | 0 | |
|
2023-07-29 | Pets at home #dogs ๐ถ๐ #offtopic | 0:56 | 29 | |
|
2023-07-28 | Pets at home #dogs ๐ถ๐ #offtopic | 1:53 | 39 | |
|
2023-07-26 | Suicide inhibitors | 0:56 | 16 | |
|
2023-07-26 | Prostaglandin synthesis | 6:13 | 77 | |
|
2023-07-26 | Competitive vs non competitive inhibitors | 0:56 | 23 | |
|
2023-07-26 | Phospholipids types | 1:42 | 10 | |
|
2023-07-26 | Reversible vs irreversible inhibition | 0:56 | 43 | |
|
2023-07-26 | Tay Sachs disease | 1:15 | 5 | |
|
2023-07-26 | Enzymatic covalent modifications | 0:56 | 9 | |
|
2023-07-26 | Sphingolipidosis - lipid storage diseases | 3:09 | 2 | |
|
2023-07-26 | Enzyme classification part 2 | 0:56 | 35 | |
|
2023-07-26 | Sphingolipidosis - lipid storage diseases part 2 | 3:04 | 2 | |
|
2023-07-25 | Enzyme classification | 0:56 | 0 | |
|
2023-07-25 | Sphingolipidosis - overview | 3:13 | 35 | |
|
2023-07-25 | Bilirubin metabolism | 0:56 | 1 | |
|
2023-07-25 | Fabrys disease | 2:14 | 4 | |
|
2023-07-25 | Lead poisoning | 0:56 | 3 | |
|
2023-07-25 | Metabolic disorders - inheritance pattern | 1:03 | 13 | |
|
2023-07-25 | Barbiturates precipitates porphyria mechanism | 0:56 | 20 | |
|
2023-07-25 | Cholesterol synthesis | 3:38 | 0 | |
|
2023-07-25 | Heme biosynthesis | 0:56 | 11 | |
|
2023-07-25 | Lipoprotein and apolipoproteins | 1:29 | 20 | |
|
2023-07-25 | Lipoprotein and apolipoproteins | 0:56 | 1 | |
|
2023-07-25 | Heme biosynthesis | 5:08 | 0 | |
|
2023-07-25 | Cholesterol synthesis | 0:56 | 5 | |
|
2023-07-25 | Barbiturates precipitates porphyria mechanism | 1:09 | 16 | |
|
2023-07-25 | Metabolic disorders - inheritance pattern | 0:56 | 6 | |
|
2023-07-25 | Lead poisoning | 1:26 | 82 | |
|
2023-07-25 | Fabrys disease | 0:56 | 5 | |
|
2023-07-25 | Bilirubin metabolism | 2:14 | 14 | |
|
2023-07-25 | Sphingolipidosis - overview | 0:56 | 12 | |
|
2023-07-25 | Enzyme classification | 1:45 | 25 | |
|
2023-07-25 | Sphingolipidosis - lipid storage diseases part 2 | 0:56 | 48 | |
|
2023-07-25 | Enzyme classification part 2 | 2:37 | 7 | |
|
2023-07-25 | Sphingolipidosis - lipid storage diseases | 0:56 | 12 | |
|
2023-07-25 | Enzymatic covalent modifications | 0:34 | 1 | |
|
2023-07-24 | Tay Sachs disease | 0:56 | 15 | |
|
2023-07-24 | Reversible vs irreversible inhibition | 1:59 | 0 | |
|
2023-07-24 | Phospholipids types | 0:56 | 1 | |
|
2023-07-24 | Competitive vs non competitive inhibitors | 3:42 | 3 | |
|
2023-07-24 | Prostaglandin synthesis | 0:56 | 16 | |
|
2023-07-24 | Suicide inhibitors | 1:06 | 41 | |
|
2023-07-21 | Important health days | 2:18 | 18 | |
|
2023-07-21 | Important health days | 0:56 | 4 | |
|
2023-07-21 | Breaking bad news | 1:43 | 2 | |
|
2023-07-21 | Breaking bad news | 0:56 | 19 | |
|
2023-07-21 | Personal protective equipment | 1:07 | 0 | |
|
2023-07-21 | Personal protective equipment | 0:56 | 7 | |
|
2023-07-21 | Post disaster phase diseases | 0:41 | 36 | |
|
2023-07-21 | Post disaster phase diseases | 0:56 | 10 | |
|
2023-07-21 | Biomedical waste disposal part 2 | 3:28 | 0 | |
|
2023-07-21 | Biomedical waste disposal part 2 | 0:56 | 22 | |
|
2023-07-21 | Biomedical waste disposal | 3:12 | 9 | |
|
2023-07-21 | Biomedical waste disposal | 0:56 | 10 | |
|
2023-07-21 | Specific insecticides | 4:37 | 0 | |
|
2023-07-21 | Specific insecticides | 0:56 | 31 | |
|
2023-07-21 | Insecticides - contact poisons | 5:37 | 5 | |
|
2023-07-21 | Insecticides - contact poisons | 0:56 | 18 | |
|
2023-07-21 | Diseases associated with rodents | 2:17 | 50 | |
|
2023-07-21 | Diseases associated with rodents | 0:56 | 18 | |
|
2023-07-21 | Arthropod borne diseases part 3 | 3:30 | 13 | |
|
2023-07-21 | Arthropod borne diseases part 3 | 0:56 | 57 | |
|
2023-07-21 | Arthropod borne diseases part 2 | 3:12 | 2 | |
|
2023-07-20 | Arthropod borne diseases part 2 | 0:56 | 29 | |
|
2023-07-20 | Arthropod borne diseases | 2:40 | 84 | |
|
2023-07-20 | Arthropod borne diseases | 0:56 | 37 | |
|
2023-07-20 | Types of vaccines | 0:56 | 10 | |
|
2023-07-20 | Types of vaccines part 2 | 1:51 | 43 | |
|
2023-07-20 | Ideal candidate for Intrauterine devices IUD | 0:56 | 0 | |
|
2023-07-20 | Types of vaccines | 1:35 | 50 | |
|
2023-07-20 | Modern concepts of family planning services | 0:56 | 5 | |
|
2023-07-20 | Intrauterine devices IUD - Contraindications | 1:48 | 12 | |
|
2023-07-20 | Intrauterine devices IUD - Contraindications | 0:56 | 4 | |
|
2023-07-20 | Intrauterine devices IUD - complications , side effects | 0:58 | 4 | |
|
2023-07-20 | Intrauterine devices IUD | 0:56 | 0 | |
|
2023-07-20 | Ideal candidate for Intrauterine devices IUD | 1:07 | 4 | |
|
2023-07-19 | Demographic indications | 0:56 | 1 | |
|
2023-07-19 | Intrauterine devices IUD | 1:47 | 14 | |
|
2023-07-19 | Intrauterine devices IUD - complications , side effects | 0:56 | 0 | |
|
2023-07-19 | Modern concepts of family planning services | 2:14 | 3 | |
|
2023-07-19 | Types of vaccines part 2 | 0:56 | 0 | |
|
2023-07-19 | Demographic indications | 1:20 | 4 | |
|
2023-07-12 | Borderline Lepromatous Leprosy | 3:15 | 12 | |
|
2023-07-12 | Borderline Leprosy | 3:22 | 11 | |
|
2023-07-12 | Borderline Lepromatous Leprosy | 0:56 | 8 | |
|
2023-07-12 | Borderline tuberculoid Leprosy | 3:31 | 12 | |
|
2023-07-12 | Human diseases caused by rickettsia and oriental species | 0:56 | 23 | |
|
2023-07-12 | Tuberculoid Leprosy | 2:38 | 3 | |
|
2023-07-12 | WHO post exposure prophylaxis in HIV | 0:56 | 3 | |
|